Home Bright Minds Biosciences

Bright Minds Biosciences

In operation
IPO
Pharmaceutical R&D and Manufacturer

Basic Information

Bright Minds Bio is a pharmaceutical company with a team composed of neuroscientists, drug developers, and doctors, committed to addressing major issues in mental health and neurology. The company focuses on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. It is advancing potential targeted therapies by leveraging its world-class scientific and drug development expertise through the use of serotonergic compounds, aiming to introduce the next generation of safe and effective drugs to improve the treatment of mental health and neurological disorders. Bright Minds’ drugs enhance the therapeutic effects of psychedelics and other serotonergic compounds while minimizing side effects, creating superior medications compared to first-generation compounds like psilocybin.
Bright Minds Biosciences, Inc.
Vancouver,BritishColumbia,Canada
less than 15 people
May 13, 2019
info@brightmindsbio.com